VCEL Stock Analysis: Buy, Sell, or Hold?

VCEL - Vericel Corporation

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$42.68
0.57 (1.35%) ▲
5d: -3.44%
30d: -5.25%
90d: +21.42%
WAIT
LOW Confidence
Protect Your VCEL Gains
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 30, 2026 0d

Get Alerted When VCEL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 MIXED SIGNALS: VCEL shows conflicting indicators. Wait for confirmation before entering.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$41.19
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.57
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: VCEL is currently trading at $42.68, which is considered oversold relative to its 30-day fair value range of $43.84 to $46.56. The stock's valuation (Forward PE: 50.5) is in line with its historical norms (52.4). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This pessimistic expectation contrasts with the company's recent 18.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, VCEL is in a strong uptrend. The price is currently testing key support at $41.68. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: VCEL scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (19th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $60.57 (+41.9%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $43.84 - $46.56
Company Quality Score 53/100 (HOLD)
Options IV Signal 19th percentile (LOW)
Volume Confirmation HIGH
Confidence Score 65.4%

Protect Your Profits

Holding VCEL? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 19th percentile)
  • BEARISH: Weak technical setup (31/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 41.9% below Wall St target ($60.57)
  • WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $43.84 - $46.56
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$3.30 (7.7%)

Support & Resistance Levels

Support Level $41.68
Resistance Level $46.13
Current Trend Strong Uptrend
Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 50.45
Wall Street Target $60.57 (+41.9%)
Revenue Growth (YoY) 22.5%
Earnings Growth (YoY) 18.9%
Profit Margin 7.9%
Valuation Discount vs History -1.2% cheaper
PE vs Historical 50.5 vs 52.4 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -1.2% (market-implied from PE analysis)
1-Year Target $42.17 (-1%)
2-Year Target $41.66 (-2%)
3-Year Target $41.16 (-4%)
3-Yr Target (if PE normalizes) (PE: 50→52) $42.75 (+0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 50.4, Growth: 64.0%) $144.04 (+238%)
Base: (SPY PE: 20.1, Growth: 64.0%) $57.30 (+34%)
Bear: (PE: 17.1, Growth: 64.0%) $48.71 (+14%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (88x PE), but valuation improves significantly next year (50x PE) as earnings recover.
Trailing PE: 87.73 | Current EPS (TTM): $0.48
Bull Case $81.64 (+91%)
Analyst growth 76.2%, PE expands to 96.5
Base Case $74.22 (+74%)
Market implied 76.2%, PE stable at 87.7
Bear Case $28.63 (-33%)
Severe decline -20.0%, PE contracts to 74.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 50.4 to 52.4
Stabilization Target: $44.33 (+3.9%)
PE Expansion Potential: +3.9%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 23, 2026 3:39 PM ET
Data refreshes hourly during market hours. Next update: 4:39 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jonathan Mark Hopper SELL 3472 shares 2026-04-02

Unlock Insider Activity

See real-time buying/selling by company executives for VCEL.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$24 33 SELL
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$840 34 SELL
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$281 55 HOLD
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$29 49 HOLD
DYN
Dyne Therapeutics Inc
STRONG BUY
14 analysts
$39 52 HOLD

Advanced VCEL Option Strategies

Professional options setups generated by AI based on today's VCEL price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for VCEL

VCEL Technical Chart VCEL Price Prediction VCEL Earnings Date VCEL Investment Advisor VCEL Fair Price Analyzer VCEL Options Advisor VCEL Options Chain VCEL Options Analysis VCEL Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals